ColoSense is designed for adults aged 45 to 85 years who are considered at average risk for colorectal cancer.

The nationwide rollout, which Labcorp disclosed Monday, comes weeks after the Centers for Medicare and Medicaid Services approved coverage for ColoSense, and the American Cancer Society named the test ...

A new blood test for colorectal cancer screening is being implemented in Alabama to improve early detection and reduce deaths from the disease.

Nearly 18 million women in the U.S. aged 45 to 64 years are likely overdue for breast, cervical or colorectal cancer screenings, and more than 3 million are estimated to not be up to date on all three ...